MedPath

Lidocaine

LIDOCAINE OINTMENT USP, 5% (Spearmint Flavored)

Approved
Approval ID

7d4cc646-5678-4dc7-9f8d-e34347d52981

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 20, 2023

Manufacturers
FDA

Preferred Pharmaceuticals Inc.

DUNS: 791119022

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68788-7865
Application NumberANDA086724
Product Classification
M
Marketing Category
C73584
G
Generic Name
Lidocaine
Product Specifications
Route of AdministrationTOPICAL
Effective DateJuly 20, 2023
FDA Product Classification

INGREDIENTS (4)

LidocaineActive
Quantity: 50 mg in 1 g
Code: 98PI200987
Classification: ACTIB
polyethylene glycol 400Inactive
Code: B697894SGQ
Classification: IACT
polyethylene glycol 3350Inactive
Code: G2M7P15E5P
Classification: IACT
propylene glycolInactive
Code: 6DC9Q167V3
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lidocaine - FDA Drug Approval Details